Home > Insider Trading > Filing (0001209191-21-040770)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651944	Dermtech Inc.	DMTK	Services-Medical Laboratories (8071)	842870849

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1739840	Michael Todd Wood	C/O Dermtech, Inc. 11099 N. Torrey Pines Rd. Suite 100 La Jolla CA 92037	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-06-11	1,398	$41.08	151,121	No	4	S	Direct
Common Stock	Disposition	2021-06-11	795	$41.37	150,326	No	4	S	Direct
Common Stock	Disposition	2021-06-14	1,689	$41.22	148,637	No	4	S	Direct
Common Stock	Disposition	2021-06-14	901	$41.84	147,736	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on June 24, 2020.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12,2021.
This transaction was executed in multiple trades at prices ranging from $41.30 to $41.42, inclusive. The reported price reflects the weighted averagesale price.
This transaction was executed in multiple trades at prices ranging from $40.65 to $41.64, inclusive. The reported price reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $41.65 to $41.99, inclusive. The reported price reflects the weighted average sale price.
The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a securityholder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3)through (5) of this Form 4.